Disease susceptibility
MONDO:0042489A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
Also known as: diatheses, diathesis, disease susceptibilities, susceptibilities, disease, susceptibility, disease
1317 clinical trials for this condition and its sub-types, 3 tagged with Disease susceptibility itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease susceptibility
-
Inherited disease susceptibility 81 trials · 1,314 incl. sub-types
284 sub-types
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Diabetes mellitus, insulin-dependent, X-linked, susceptibility to 0 trials · 178 incl. sub-types Sub-types →
- Lumbar disk herniation, susceptibility to 96 trials
- Urinary tract infections, recurrent, susceptibility to 40 trials
- Osteoarthritis susceptibility 6 37 trials
- Pregnancy loss, recurrent, susceptibility 21 trials · 32 incl. sub-types Sub-types →
- IgA nephropathy, susceptibility to 0 trials · 16 incl. sub-types Sub-types →
- Osteoarthritis susceptibility 2 16 trials
- Essential hypertension, genetic 14 trials
- Osteoarthritis susceptibility 5 13 trials
- Polysubstance abuse, susceptibility to 10 trials
- Osteoarthritis susceptibility 1 8 trials
- Autism, susceptiblity to 0 trials · 7 incl. sub-types Sub-types →
- Focal segmental glomerulosclerosis 4, susceptibility to 7 trials
- GBA1-related Parkinson disease, susceptibility 6 trials
- Neural tube defects, susceptibility to 6 trials
- Otitis media, susceptibility to 5 trials
- Pulmonary edema of mountaineers, susceptibility to 5 trials
- Exfoliation syndrome, susceptibility to 4 trials
- Pelvic organ prolapse, susceptibility to 4 trials
- Breast-ovarian cancer, familial, susceptibility to 0 trials · 3 incl. sub-types Sub-types →
- Inherited susceptibility to asthma 2 trials · 3 incl. sub-types Sub-types →
- Diabetes mellitus, ketosis-prone 2 trials
- Microvascular complications of diabetes, susceptibility 2 trials Sub-types →
- Alzheimer disease 9 1 trial
- Helicobacter pylori infection, susceptibility to 1 trial
- UV-induced skin damage, susceptibility to 1 trial
- Antisocial behavior, susceptibility to 1 trial
- Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency 1 trial
- Coronary artery disease, severe, susceptibility to 1 trial
- Familial meningioma 1 trial
- Hearing loss, cisplatin-induced, susceptibility to 1 trial
- Hemorrhage, intracerebral, susceptibility to 1 trial
- Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection 1 trial
- Hepatitis C virus, susceptibility to 1 trial
- Inherited susceptibility to mycobacterial diseases 1 trial Sub-types →
- Nephrolithiasis, uric acid, susceptibility to 1 trial
- Predisposition to invasive fungal disease due to CARD9 deficiency 1 trial
- Tobacco addiction, susceptibility to 1 trial
- Alzheimer disease, susceptibility to, mitochondrial 0 trials
- Ascaris lumbricoides infection, susceptibility to 0 trials
- Asperger syndrome, susceptibility to 0 trials Sub-types →
- Buruli ulcer, susceptibility to 0 trials
- Graves disease, susceptibility to, 1 0 trials
- Graves disease, susceptibility to, X-linked 2 0 trials
- Hirschsprung disease, susceptibility to 0 trials Sub-types →
- Leber optic atrophy, susceptibility to 0 trials
- Mycobacterium tuberculosis, susceptibility 0 trials Sub-types →
- Parkinson disease 11, autosomal dominant, susceptibility to 0 trials
- Parkinson disease 13, autosomal dominant, susceptibility to 0 trials
- Parkinson disease 18, autosomal dominant, susceptibility to 0 trials
- Parkinson disease 24, autosomal dominant, susceptibility to 0 trials
- Parkinson disease 26, autosomal dominant, susceptibility to 0 trials
- Parkinson disease 5, autosomal dominant, susceptibility to 0 trials
- SH2B3-related immune system disorder 0 trials
- Schistosoma mansoni infection, susceptibility/resistance to 0 trials
- West Nile virus, susceptibility to 0 trials
- Age related macular degeneration, susceptibility to 0 trials Sub-types →
- Allergic rhinitis, susceptibility to 0 trials
- Amyotrophic lateral sclerosis, susceptibility to, 13 0 trials
- Amyotrophic lateral sclerosis, susceptibility to, 24 0 trials
- Amyotrophic lateral sclerosis, susceptibility to, 25 0 trials
- Anorexia nervosa, susceptibility to, 1 0 trials
- Aortic aneurysm, familial thoracic 11, susceptibility to 0 trials
- Aplastic anemia, susceptibility to 0 trials
- Appendicitis, proneness to 0 trials
- Aspergillosis, susceptibility to 0 trials
- Atherosclerosis susceptibility 0 trials
- Atrioventricular septal defect, susceptibility to, 1 0 trials
- Atrioventricular septal defect, susceptibility to, 2 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 1 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 2 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 3 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 4 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 5 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 6 0 trials
- Attention deficit-hyperactivity disorder, susceptibility to, 7 0 trials
- Autoimmune disease, susceptibility to, 1 0 trials
- Autoimmune disease, susceptibility to, 2 0 trials
- Autoimmune disease, susceptibility to, 3 0 trials
- Autoimmune disease, susceptibility to, 4 0 trials
- Autoimmune disease, susceptibility to, 5 0 trials
- Autoimmune disease, susceptibility to, 6 0 trials
- Autoimmune thyroid disease, susceptibility to 0 trials Sub-types →
- Autoimmune thyroid disease, susceptibility to, 5 0 trials
- Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency 0 trials
- Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency 0 trials
- Bacteremia, susceptibility 0 trials Sub-types →
- Basal cell carcinoma, susceptibility to 0 trials Sub-types →
- Bleeding disorder, platelet-type, 13, susceptibility to 0 trials
- Blepharospasm, benign essential, susceptibility to 0 trials
- Bulimia nervosa, susceptibility to, 1 0 trials
- Cardiomyopathy, familial hypertrophic, 4, susceptibility to 0 trials
- Celiac disease, susceptibility to, 1 0 trials
- Celiac disease, susceptibility to, 10 0 trials
- Celiac disease, susceptibility to, 11 0 trials
- Celiac disease, susceptibility to, 12 0 trials
- Celiac disease, susceptibility to, 13 0 trials
- Celiac disease, susceptibility to, 2 0 trials
- Celiac disease, susceptibility to, 3 0 trials
- Celiac disease, susceptibility to, 4 0 trials
- Celiac disease, susceptibility to, 5 0 trials
- Celiac disease, susceptibility to, 6 0 trials
- Celiac disease, susceptibility to, 7 0 trials
- Celiac disease, susceptibility to, 8 0 trials
- Celiac disease, susceptibility to, 9 0 trials
- Chronic mountain sickness, susceptibility to 0 trials
- Cirrhosis, noncryptogenic, susceptibility to 0 trials
- Coronary heart disease, susceptibility to, 1 0 trials
- Coronary heart disease, susceptibility to, 2 0 trials
- Coronary heart disease, susceptibility to, 3 0 trials
- Coronary heart disease, susceptibility to, 4 0 trials
- Coronary heart disease, susceptibility to, 5 0 trials
- Coronary heart disease, susceptibility to, 6 0 trials
- Coronary heart disease, susceptibility to, 7 0 trials
- Coronary heart disease, susceptibility to, 8 0 trials
- Coronary heart disease, susceptibility to, 9 0 trials
- Craniosynostosis 5, susceptibility to 0 trials
- Craniosynostosis 7 0 trials
- Delayed sleep phase syndrome, susceptibility to 0 trials
- Dengue fever, susceptibility to 0 trials
- Dengue hemorrhagic fever, susceptibility to 0 trials
- Dengue shock syndrome, susceptibility to 0 trials
- Dengue virus, susceptibility to 0 trials
- Dermatitis, atopic, susceptibility to 0 trials Sub-types →
- Dyslexia, susceptibility to, 1 0 trials
- Dyslexia, susceptibility to, 2 0 trials
- Dyslexia, susceptibility to, 3 0 trials
- Dyslexia, susceptibility to, 4 0 trials
- Dyslexia, susceptibility to, 5 0 trials
- Dyslexia, susceptibility to, 6 0 trials
- Dyslexia, susceptibility to, 7 0 trials
- Dyslexia, susceptibility to, 8 0 trials
- Dyslexia, susceptibility to, 9 0 trials
- Dystonia 38, susceptibility to 0 trials
- Efavirenz central nervous system toxicity, susceptibility to 0 trials
- Encephalitis, acute, infection-induced, susceptibility to 0 trials Sub-types →
- Endometriosis, susceptibility to, 1 0 trials
- Epidermodysplasia verruciformis, susceptibility to 0 trials Sub-types →
- Epilepsy, childhood absence, susceptibility to, 1 0 trials
- Epilepsy, childhood absence, susceptibility to, 5 0 trials
- Epilepsy, childhood absence, susceptibility to, 6 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 1 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 10 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 12 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 13 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 14 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 15 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 16 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 17 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 18 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 19 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 2 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 3 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 4 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 5 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 6 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 7 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 8 0 trials
- Epilepsy, idiopathic generalized, susceptibility to, 9 0 trials
- Epilepsy, juvenile absence, susceptibility to 0 trials Sub-types →
- Epilepsy, juvenile myoclonic, susceptibility to, 10 0 trials
- Epilepsy, juvenile myoclonic, susceptibility to, 6 0 trials
- Epilepsy, juvenile myoclonic, susceptibility to, 9 0 trials
- Fatty liver disease, nonalcoholic, susceptibility to, 2 0 trials
- Focal segmental glomerulosclerosis 3, susceptibility to 0 trials
- Gallbladder disease 4 0 trials
- Glaucoma, normal tension, susceptibility to 0 trials
- Graft-versus-host disease, susceptibility to 0 trials
- Hearing loss, noise-induced, susceptibility to 0 trials
- Hemolytic uremic syndrome, atypical, susceptibility to, 1 0 trials Sub-types →
- Hemolytic uremic syndrome, atypical, susceptibility to, 7 0 trials
- Hepatitis B virus, susceptibility to 0 trials
- Hepatitis, fulminant viral, susceptibility to 0 trials
- Herpes simplex encephalitis, susceptibility to, 1 0 trials
- Herpes simplex encephalitis, susceptibility to, 2 0 trials
- Herpes simplex encephalitis, susceptibility to, 3 0 trials
- Herpes simplex encephalitis, susceptibility to, 4 0 trials
- Herpes simplex encephalitis, susceptibility to, 7 0 trials
- Human herpesvirus 8, susceptibility to 0 trials
- Hydrocephalus, congenital, 5, susceptibility to 0 trials
- Hyperemesis gravidarum, susceptibility to 0 trials
- Hyperlipidemia, combined, 1 0 trials
- Hypertension, essential, susceptibility to, 1 0 trials
- Hypertension, essential, susceptibility to, 2 0 trials
- Hypertension, essential, susceptibility to, 3 0 trials
- Hypertension, essential, susceptibility to, 4 0 trials
- Hypertension, essential, susceptibility to, 5 0 trials
- Hypertension, essential, susceptibility to, 6 0 trials
- Hypertension, essential, susceptibility to, 7 0 trials
- Hypertension, essential, susceptibility to, 8 0 trials
- Hypervitaminosis a, susceptibility to 0 trials
- Influenza, severe, susceptibility to 0 trials
- Iron overload, susceptibility to 0 trials
- Kuru, susceptibility to 0 trials
- Legionnaire disease, susceptibility to 0 trials
- Leishmaniasis, tegumentary, susceptibility to 0 trials
- Leprosy, susceptibility to, 1 0 trials
- Leprosy, susceptibility to, 2 0 trials
- Leprosy, susceptibility to, 3 0 trials
- Leprosy, susceptibility to, 4 0 trials
- Leprosy, susceptibility to, 5 0 trials
- Leprosy, susceptibility to, 6 0 trials
- Lipodystrophy, partial, acquired, susceptibility to 0 trials
- Lumbar disk degeneration, susceptibility to 0 trials
- Major depressive disorder 1 0 trials
- Major depressive disorder 2 0 trials
- Malaria, susceptibility to 0 trials Sub-types →
- Malignant hyperthermia, susceptibility to 0 trials Sub-types →
- Melioidosis, susceptibility to 0 trials
- Migraine with or without aura, susceptibility to 0 trials Sub-types →
- Multicentric Castleman disease, susceptibility to 0 trials
- Multiple sclerosis, susceptibility to 0 trials Sub-types →
- Multiple system atrophy 1, susceptibility to 0 trials
- Myocardial infarction, susceptibility to 0 trials
- Myocardial infarction, susceptibility to, 2 0 trials
- Myoclonic epilepsy, juvenile, susceptibility to, 1 0 trials
- Myoclonic epilepsy, juvenile, susceptibility to, 3 0 trials
- Myoclonic epilepsy, juvenile, susceptibility to, 4 0 trials
- Narcolepsy, susceptibility to 0 trials Sub-types →
- Nephrolithiasis susceptibility caused by SLC26A1 0 trials
- Nonarteritic anterior ischemic optic neuropathy, susceptibility to 0 trials
- Obesity, susceptibility to 0 trials
- Opioid dependence, susceptibility to, 1 0 trials
- Orofacial cleft 6, susceptibility to 0 trials
- Osteoarthritis susceptibility 3 0 trials
- Osteoarthritis susceptibility 4 0 trials
- Pelvic organ prolapse, susceptibility to, 1 0 trials
- Pelvic organ prolapse, susceptibility to, 2 0 trials
- Peripartum cardiomyopathy, susceptibility to 0 trials
- Podoconiosis, susceptibility to 0 trials
- Polycystic kidney disease 9, susceptibility to 0 trials
- Psoriasis, susceptibility to 0 trials Sub-types →
- Psoriatic arthritis, susceptibility to 0 trials Sub-types →
- Pulmonary disease, chronic obstructive, susceptibility to 0 trials
- Pulmonary hypertension, neonatal, susceptibility to 0 trials
- Radioulnar synostosis, nonsyndromic, susceptibility to 0 trials
- Renal dysplasia, cystic, susceptibility to 0 trials
- Restless legs syndrome, susceptibility to 0 trials Sub-types →
- Rhabdomyolysis, susceptibility to 0 trials Sub-types →
- Sarcoidosis, susceptibility to, 1 0 trials
- Sarcoidosis, susceptibility to, 2 0 trials
- Sarcoidosis, susceptibility to, 3 0 trials
- Schizophrenia, susceptibility to 0 trials Sub-types →
- Scoliosis, isolated, susceptibility to 0 trials Sub-types →
- Seasonal affective disorder, susceptibility to 0 trials
- Sick sinus syndrome 3, susceptibility to 0 trials
- Spondyloarthropathy, susceptibility to 0 trials Sub-types →
- Strabismus, susceptibility to 0 trials Sub-types →
- Stroke, susceptibility to, 1 0 trials
- Susceptibility to HIV infection 0 trials
- Susceptibility to angioedema induced by ACE inhibitors 0 trials
- Susceptibility to localized juvenile periodontitis 0 trials
- Susceptibility to mononeuropathy of the median nerve, mild 0 trials
- Susceptibility to respiratory infections associated with CD8alpha chain mutation 0 trials
- Susceptibility to visceral leishmaniasis, 1 0 trials
- Susceptibility to visceral leishmaniasis, 2 0 trials
- Susceptibility to visceral leishmaniasis, 3 0 trials
- Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1 0 trials
- Systemic lupus erythematosus with nephritis, susceptibility to, 1 0 trials
- Systemic lupus erythematosus with nephritis, susceptibility to, 2 0 trials
- Systemic lupus erythematosus with nephritis, susceptibility to, 3 0 trials
- Systemic lupus erythematosus, susceptibility to, 1 0 trials
- Systemic lupus erythematosus, susceptibility to, 10 0 trials
- Systemic lupus erythematosus, susceptibility to, 11 0 trials
- Systemic lupus erythematosus, susceptibility to, 12 0 trials
- Systemic lupus erythematosus, susceptibility to, 13 0 trials
- Systemic lupus erythematosus, susceptibility to, 14 0 trials
- Systemic lupus erythematosus, susceptibility to, 15 0 trials
- Systemic lupus erythematosus, susceptibility to, 2 0 trials
- Systemic lupus erythematosus, susceptibility to, 3 0 trials
- Systemic lupus erythematosus, susceptibility to, 4 0 trials
- Systemic lupus erythematosus, susceptibility to, 5 0 trials
- Systemic lupus erythematosus, susceptibility to, 6 0 trials
- Systemic lupus erythematosus, susceptibility to, 7 0 trials
- Systemic lupus erythematosus, susceptibility to, 8 0 trials
- Systemic lupus erythematosus, susceptibility to, 9 0 trials
- Thyrotoxic periodic paralysis, susceptibility to, 1 0 trials
- Thyrotoxic periodic paralysis, susceptibility to, 2 0 trials
- Thyrotoxic periodic paralysis, susceptibility to, 3 0 trials
- Ventricular fibrillation during myocardial infarction, susceptibility to 0 trials
- Vitiligo-associated multiple autoimmune disease susceptibility 1 0 trials
- Vitiligo-associated multiple autoimmune disease susceptibility 6 0 trials
- Xanthomatosis, susceptibility to 0 trials
Most studied deeper sub-types
Type 1 diabetes mellitus 1
(146)
Glioma susceptibility 1
(133)
Lynch syndrome
(81)
Neurofibromatosis type 1
(73)
Leukemia, acute lymphocytic, susceptibility to, 1
(41)
Tuberous sclerosis
(41)
BRCA2-related cancer predisposition
(36)
Hereditary breast ovarian cancer syndrome
(35)
Mismatch repair cancer syndrome 1
(34)
Multiple endocrine neoplasia type 1
(34)
Classic familial adenomatous polyposis
(33)
Tuberous sclerosis 1
(33)
Type 1 diabetes mellitus 12
(26)
BRCA1-related cancer predisposition
(23)
Familial medullary thyroid carcinoma
(23)
Nasopharyngeal carcinoma, susceptibility to, 1
(21)
NF2-related schwannomatosis
(21)
Neurofibromatosis
(19)
IgA nephropathy, susceptibility to, 1
(16)
Li-Fraumeni syndrome
(16)